May 11, 2020 / 1:26 PM / 18 days ago

BRIEF-Lattice Biologics Does Not Anticipate Supply Restrictions, Scalabity Issues To Complete Phase 1 Trials For COVID-19

May 11 (Reuters) - Lattice Biologics Ltd:

* LATTICE BIOLOGICS UPDATE

* LATTICE BIOLOGICS LTD - ADDITION OF CHAD GREEN, RRT, TO CLINICAL DEVELOPMENT TEAM FOR COVID-19 PHASE 1 TRIAL

* LATTICE BIOLOGICS LTD - DOES NOT ANTICIPATE SUPPLY RESTRICTIONS OR SCALABITY ISSUES TO COMPLETE PHASE 1 TRIALS FOR COVID-19

* LATTICE BIOLOGICS- LAUNCHED ADDITIONAL PRODUCTS IN Q2 FOR DENTAL MARKET WITH ADDITIONAL FACILITY EXPECTED TO BE OPERATIONAL BY AUGUST Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below